Navigation Links
CutisPharma Homogeneity and Stability Study for Mouthwash Compounding Kits Presented at NERDG Meeting
Date:5/15/2012

WOBURN, Mass., May 15, 2012 /PRNewswire/ -- CutisPharma, Inc. announced the presentation of homogeneity and stability studies for compounded formulations of several "Magic Mouthwash" suspensions using FIRST®- Unit- of- use Prescription Compounding Kits.  The poster presentation, by Anisa Gandhi, was at the April 20th American Association of Pharmaceutical Scientists, Northeast Regional Discussion Group (NERDG) Regional Meeting.

"Magic Mouthwash" is commonly prescribed by physicians nationwide.  The purpose behind magic mouthwash is to combine various ingredients with different advantages depending on the patient's symptoms.  Currently magic mouthwash is extemporaneously prepared or is prepared using FIRST® - Magic Mouthwash Compounding Kits.

The active ingredients used in these FIRST® Magic Mouthwash kits are comparable to those found in the most routinely prescribed "Magic Mouthwash" formulations.  These active ingredients are: diphenhydramine hydrochloride, lidocaine hydrochloride, and modified Maalox® in FIRST® - Mouthwash BLM; diphenhydramine hydrochloride, lidocaine hydrochloride, and nystatin in FIRST®  -BXN Mouthwash; diphenhydramine hydrochloride, hydrocortisone, and nystatin in FIRST®  - Duke's Mouthwash; and diphenhydramine hydrochloride, hydrocortisone, nystatin, and tetracycline in FIRST®  - Mary's Mouthwash.

Ms. Gandhi's presentation demonstrated that FIRST®  -Mouthwash Kits are uniform in nature for active ingredients.  FIRST®  Magic Mouthwash Kits are convenient with reliable stability and uniformity data, whereas, the traditional compounding process generally does not have this data available.

FIRST® products save dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction.  Using FIRST® Mouthwash kits, the pharmacist can compound a prescription with accuracy faster than those prepared in the conventional way.  A single NDC number assigned for the entire kit facilitates the third party reimbursement process, and reduces audit- related adjustments.

CutisPharma now has twenty proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, six Magic Mouthwash kits, three omeprazole suspension kits, and three lansoprazole suspension kits.  Several more compounding kits are in the planning stages. The use of FIRST® Unit-of-Use Prescription Compounding Kits facilitates compliance with United States Pharmacopeia (USP) Chapter <795>.

"CutisPharma is committed to maintaining the scientific integrity of the products it develops and commercializes.  Studies of this nature also demonstrate the scientific reliability of FIRST® products, as well as confirm their user-friendliness and time-saving benefits" said Dr. Indu Muni, President  & CEO of CutisPharma.

About CutisPharma
CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.

For more information please visit our website at www.cutispharma.com.


'/>"/>
SOURCE CutisPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
2. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
3. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
4. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
5. CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits
6. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
7. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. ADVENTRX Announces 9-Month Stability Data Results for ANX-530
9. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
10. Stability Testing Course is Taking the Online Training Format by Storm!
11. Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... BOCA RATON, Fla. , Jan. 19, 2017 ... ), a medical device company specializing in the ... conditions, such as keloids, with superficial radiation therapy, ... quarter and full year 2016 financial results on Thursday, ... The Company will hold a conference call ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
Breaking Medicine Technology:
(Date:1/19/2017)... Florida (PRWEB) , ... January 19, 2017 , ... ... dollar 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy located ... meet the growing demand of physicians and patients throughout the United States for ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it will be co-hosting a ... innovative excipients and drug delivery solutions to health industries worldwide. The one day ...
(Date:1/19/2017)... ... January 19, 2017 , ... In ... administered fillers that resulted in severe facial disfiguration. After four frightening years of ... doctors at UCLA Medical Center, who removed the substances in a partial facial ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate Medical Academy (UMA) is ... passionate about making a difference in the lives of the next generation of ... nonprofit healthcare educational institution, has more than 30,000 alumni and employs more than ...
Breaking Medicine News(10 mins):